Article
A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer - Nature Communications
Rating:
0.0
Views:
38
Likes:
1
Library:
1
There are few effective treatments for small cell lung cancer (SCLC) underscoring the need for innovative therapeutic approaches. This study focuses on exploiting telomerase, a critical SCLC dependency as a therapeutic target. A prominent characteristic of SCLC is their reliance on telomerase activity, a key enzyme essential for their continuous proliferation.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value